Biotech news
Pharma
Panellists discussed the potential impact of the UK’s decision to leave the EU on patents yesterday at the 2017 BIO International Convention. 22 June 2017
Americas
Academic patents and their subsequent licensing contributed up to $1.3 trillion to US industry gross output between 1996 and 2015, the Biotechnology Innovation Organization has found. 22 June 2017
Biotech
Google’s parent company Alphabet has invested $300 million in a new fund that will buy stakes in European biotech companies. 21 June 2017
Americas
“I will think about this every day until the day I die … whether there was something more we could have done to have won the [Brexit] referendum,” said former UK Prime Minister David Cameron. 21 June 2017
Africa
The creator of OmniRat, the first human monoclonal antibody technology based on rats, outlined the success story of the project yesterday at the 2017 BIO International Convention. 20 June 2017
Americas
The biopharma industry must do its part in changing the public's view of the sector, because the political reality is that it is unpopular, according to Brent Saunders, chairman, president and CEO of Allergan. 20 June 2017
Asia-Pacific
Merck has been granted its first CRISPR technology patent by the Australian Patent Office. 16 June 2017
Americas
The Patent Trial and Appeal Board is not a “death squad” for drug patents, according to a study conducted by Fitzpatrick, Cella, Harper & Scinto. 15 June 2017
Americas
The US Supreme Court’s decision in the Amgen and Sandoz clash, which was handed down yesterday, has sparked disagreement between lawyers on the consequences of the ruling. 13 June 2017
Americas
The US Supreme Court has ruled that biosimilar applicants may provide notice to the manufacturer before obtaining a licence from the Food and Drug Administration for their biosimilars. 12 June 2017